Dr. Dustin Ryan Fraidenburg, MD

Dr. Fraidenburg practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Dr. Fraidenburg's NPI, 1235365586, was assigned on June 1, 2009. Dr. Fraidenburg graduated from Wayne State University School of Medicine in 2009. Dr. Fraidenburg holds Illinois license 036.131110.

Dr. Fraidenburg's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Dr. Fraidenburg's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is University of Illinois Physicians Group (UIPG).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fraidenburg practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Fraidenburg's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Fraidenburg is licensed in Illinois.

CMS data shows 289 Medicare services from Dr. Fraidenburg across 7 procedure codes in 2024, for 140 Medicare patients. Medicare paid $21,027 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 140 Medicare patients who saw Dr. Fraidenburg in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 65% are also on Medicaid. Their average risk score is 3.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fraidenburg's median patient age at 68, with 69% women.

In 2024, Dr. Fraidenburg wrote 881 Medicare Part D claims for 72 patients. 53% of them were for generic drugs. CMS names the drug for 784 of them, across 13 drugs with 11 or more claims each, at $5,460,937 in total drug cost. In 2023, CMS named 874 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Fraidenburg for performance year 2024, reported as part of a group. Dr. Fraidenburg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fraidenburg as offering telehealth.

Dmand AI links 30 papers to Dr. Fraidenburg, published from 2012 to 2025. 2014 was the busiest year, with 4. The most frequent topics are Hypertension, Pulmonary, Influenza A Virus, H7N9 Subtype and Influenza, Human. Dr. Fraidenburg has published most often in Am J Physiol Lung Cell Mol Physiol. Dr. Fraidenburg's most frequent co-authors are Janae J. Gonzales, MD, Roberto Ferreira P. Machado, MD and Kelsey Holbert.

Dmand AI links Dr. Fraidenburg to 7 clinical trials, 4 of them phase 3 studies. Conditions studied include Hypertension, Pulmonary, Pulmonary Arterial Hypertension and Hypertension. United Therapeutics sponsors the most, 4. Open Payments lists research payments to Dr. Fraidenburg that name 2 trials.

CMS Open Payments shows 60 general payments to Dr. Fraidenburg from 5 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 56% of the total. United Therapeutics Corporation paid the most, $8,636. It also lists 14 research payments totaling $2,698 from 2018 to 2024, naming 2 clinical trials.

Dr. Fraidenburg graduated from Wayne State University School of Medicine in 2009.